Novel Inflammation Marker May Predict Coronary Artery Lesions in Kawasaki Disease
The C-reactive protein to albumin ratio is a novel inflammation marker that may be a valuable predictor of coronary artery lesion formation in Kawasaki disease.
Cardiovascular Disease
Combined Use of Risk Algorithms Predicts Carotid Plaques in Patients With Rheumatoid Arthritis
Researchers evaluated the combined use of the European SCORE and QRISK3 algorithms as predictors of carotid plaques in patients with rheumatoid arthritis.
Glucocorticoid Use Tied to CVD Risk in Immune-Mediated Diseases
For patients with six immune-mediated inflammatory diseases, the risk for CVD is increased in association with glucocorticoid dose.
A Closer Look at Cardiovascular Disease Risk in Patients With Systemic Lupus Erythematosus
An overview of the increased risk for cardiovascular disease in patients with systemic lupus erythematosus.
No Increased Cardiovascular Risk With Febuxostat vs Allopurinol in Gout
In contrast to CARES, FAST found that treatment with febuxostat was not associated with an increase in cardiovascular or all-cause death compared with allopurinol in patients with gout.
Low LDL Associated With Coronary Atherosclerosis Burden, CVD Risk in Non-Obese Patients With RA
Burden and progression of coronary atherosclerosis was found to be worsened in non-obese patients with rheumatoid arthritis and low vs high LDL levels.
Thromboembolic Disorders: Treatments
Anticoagulants, antiplatelets, and thrombolytics for the treatment and/or prophylaxis of venous and arterial thrombosis.
Treatment With DMARDs Improves Cardiovascular Abnormalities in Early Rheumatoid Arthritis
Researchers determined the effect of disease-modifying antirheumatic drug therapy on patients with early rheumatoid arthritis with cardiovascular disease.
Gout May Not Be Associated With Cardiovascular Complications in Peripheral Artery Disease
Gout was not found to be associated with increased risk for cardiovascular complications in patients with peripheral artery disease.
Aspirin May Be Considered for Primary Prevention of Cardiovascular Disease in Rheumatic Diseases
Study authors reviewed the evidence on the effectiveness of low-dose aspirin in the primary prevention of cardiovascular disease in systemic autoimmune rheumatic diseases.
-
Loading...
-
Loading...
Next post in General Rheumatology
